Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
344
Intravitreal Injection of OTX-TKI (axitinib implant)
Injection of 2mg (0.05mL) of aflibercept
Best corrected visual acuity (BCVA)
Maintenance of visual acuity, defined as \< 15 Early Treatment Diabetic Retinopathy Study (ETDRS) letters Best corrected visual acuity (BCVA) loss
Time frame: Up to 36 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Associated Retina Consultants - Gilbert
Gilbert, Arizona, United States
Associated Retina Consultants - Phoenix
Phoenix, Arizona, United States
Retinal Research Institute
Phoenix, Arizona, United States
Retina Macula Institute of Arizona
Scottsdale, Arizona, United States
CA CRC California Retina Consultants
Bakersfield, California, United States
The Retina Partners - Encino
Encino, California, United States
Retina Consultants of Orange County - Fullerton
Fullerton, California, United States
Atlantis Eyecare
Huntington Beach, California, United States
Lakeside Vision Center - Irvine
Irvine, California, United States
Retina-Vitreous Associates Medical Group - Los Angeles
Los Angeles, California, United States
...and 98 more locations